CGEM vs TECH
Cullinan Oncology LLC (CGEM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CGEM currently screens at market cap $830.3M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CGEM and TECH stock pages for the full models.
Not investment advice.